Brief: Herantis Pharma H2 Loss Unchanged At EUR 4.7 Mln

Herantis Pharma Oyj

03/03/2021 06:13

March 3 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * H2 LOSS FOR PERIOD EUR 4.7 MILLION VERSUS LOSS EUR 4.7 MILLION YEAR AGO

Source text for Eikon:  ID:nWkr9ZwyNy 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))